Emergent BioSolutions 3Q Revenues: $149.4 million (+5%) 3Q Earnings: $33.6 million (+65%) YTD Revenues: $367.1 million (+9%) YTD Earnings: $48.7 million (+61%) Comments: Growth in the quarter was primarily driven by increased product sales, namely Other product sales, and contract manufacturing revenues, offset by lower contracts and grants revenue. Product sales were $114.3 million, up 18% attributable to other product sales and, specifically, sales related to the timing of BAT deliveries ...